Human medicines European public assessment report (EPAR): Mozobil, plerixafor, Multiple Myeloma,Hematopoietic Stem Cell Transplantation,Lymphoma, Date of authorisation: 30/07/2009, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871bb ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Mozobil, plerixafor, Multiple Myeloma,Hematopoietic Stem Cell Transplantation,Lymphoma, Date of authorisation: 30/07/2009, Revision: 15, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399662 ◽

2018 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 15/09/2008, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1abd963 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Filgrastim Hexal, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 06/02/2009, Revision: 16, Status: Authorised

Case Medical Research ◽

10.31525/cmr-17404b4 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Zarzio, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 06/02/2009, Revision: 17, Status: Authorised

Case Medical Research ◽

10.31525/cmr-17404aa ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 15/09/2008, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1ad6fbd ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Tevagrastim, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 15/09/2008, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1d401b2 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Busulfan Fresenius Kabi, busulfan, Hematopoietic Stem Cell Transplantation, Date of authorisation: 22/09/2014, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-12043e2 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Hematopoietic Stem Cell Transplantation, Date of authorisation: 20/06/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1851b90 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Nivestim, filgrastim, Neutropenia,Hematopoietic Stem Cell Transplantation,Cancer, Date of authorisation: 07/06/2010, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5590fc ◽

2018 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Tepadina, thiotepa, Hematopoietic Stem Cell Transplantation, Date of authorisation: 15/03/2010, Revision: 12, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1907588 ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text